Combipatch and breast disorder 
Combipatch and breast disorder Patient Reports February 10, 2012
Combipatch Side Effects Report #5382538-6
Combipatch side effect was reported by a Consumer or non-health professional from UNITED STATES on June 29, 2007. Female patient, 66 years of age, weighting 125.0 lb, was diagnosed with menopause
and was treated with Combipatch. After drug was administered, patient experienced the following side effects: anxiety , blood cholesterol increased, blood thyroid stimulating hormone increased, bone density decreased, breast cancer , breast disorder, breast mass, cataract , cataract operation. Combipatch dosage: unknown. During the same period patient was treated with PROVERA, ESTRADERM, VIVELLE, AYGESTIN, ESTRATEST, PREMARIN. Patient was hospitalized. Patient recovered.Combipatch Side Effects Report #5410822-6
Combipatch side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 03, 2007. Female patient, 64 years of age, weighting 210.0 lb, was diagnosed with menopause
, hypertension and was treated with Combipatch. After drug was administered, patient experienced the following side effects: breast cancer , breast cyst, breast disorder, breast fibrosis, breast haemorrhage, breast inflammation, breast mass, breast microcalcification, breast operation. Combipatch dosage: unknown. During the same period patient was treated with PREMPRO, ATENOLOL, LIPITOR, PREMARIN, PROVERA. Patient recovered.Combipatch Side Effects Report #5928962-1
Combipatch side effect was reported by a Consumer or non-health professional from UNITED STATES on July 14, 2008. Female patient, 61 years of age, weighting 209.9 lb, was diagnosed with menopause
and was treated with Combipatch. After drug was administered, patient experienced the following side effects: breast calcifications, breast cancer , breast cyst, breast disorder, breast fibrosis, breast haemorrhage, breast inflammation, breast mass, breast operation. Combipatch dosage: 0.5/0.25 MG, TRANSDERMAL. During the same period patient was treated with PREMPRO, PREMARIN, PROVERA, ATENOLOL, LIPITOR. Patient recovered.Combipatch Side Effects Report #5816024-3
Combipatch side effect was reported by a Consumer or non-health professional from UNITED STATES on July 14, 2008. Female patient, weighting 180.0 lb, was diagnosed with menopause
and was treated with Combipatch. After drug was administered, patient experienced the following side effects: biopsy, breast cancer , breast disorder, breast lump removal, breast neoplasm, cervix disorder, colonoscopy , heart rate irregular, hypercholesterolaemia. Combipatch dosage: 0.5 MG, UNK. During the same period patient was treated with PREMPRO, PREMARIN, ESTRADIOL, MEDROXYPROGESTERONE, PROVERA, ESTRACE. Patient recovered.Combipatch Side Effects Report #5828966-3
Combipatch side effect was reported by a Consumer or non-health professional from UNITED STATES on July 21, 2008. Female patient, weighting 125.0 lb, was diagnosed with menopause
, cardiovascular event prophylaxis, bone disorder, hot flush, vulvovaginal dryness and was treated with Combipatch. After drug was administered, patient experienced the following side effects: anxiety , blood cholesterol increased, blood thyroid stimulating hormone increased, blood triglycerides increased, bone density decreased, breast cancer , breast disorder, breast mass, cataract . Combipatch dosage: 0.25 MG, UNK. During the same period patient was treated with ESTRADERM, VIVELLE, AYGESTIN. Patient was hospitalized. Patient recovered.Combipatch Side Effects Report #6038192-3
Combipatch side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 05, 2009. Female patient, weighting 125.0 lb, was diagnosed with menopause
, cardiovascular event prophylaxis, bone disorder, hot flush, vulvovaginal dryness and was treated with Combipatch. After drug was administered, patient experienced the following side effects: anxiety , atrophic vulvovaginitis, blood cholesterol increased, blood thyroid stimulating hormone increased, blood triglycerides increased, bone density decreased, breast cancer , breast disorder, breast mass. Combipatch dosage: 0.25 MG, UNK. During the same period patient was treated with ESTRADERM, VIVELLE, AYGESTIN. Patient was hospitalized. Patient recovered.Combipatch Side Effects Report #6054939-4
Combipatch side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 23, 2009. Female patient, weighting 125.0 lb, was diagnosed with menopause
, cardiovascular event prophylaxis, bone disorder, hot flush, vulvovaginal dryness and was treated with Combipatch. After drug was administered, patient experienced the following side effects: anxiety , atrophic vulvovaginitis, blood cholesterol increased, blood thyroid stimulating hormone increased, blood triglycerides increased, bone density decreased, breast cancer , breast disorder, breast mass. Combipatch dosage: 0.25 MG, UNK. During the same period patient was treated with ESTRADERM, VIVELLE, AYGESTIN. Patient was hospitalized. Patient recovered.